Gynecomastia and semen abnormalities induced by spironolactone in normal men.
D000328:Adult; D002191:Canrenoic Acid / Q000097:blood; D002192:Canrenone / Q000097:blood; D004958:Estradiol / Q000097:blood; D005640:Follicle Stimulating Hormone / Q000097:blood; D006177:Gynecomastia / Q000097:blood* / Q000139:chemically induced; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D010902:Pituitary Gland / Q000187:drug effects* / Q000502:physiology; D013081:Sperm Motility / Q000187:drug effects; D013094:Spermatozoa / Q000187:drug effects / Q000502:physiology*; D013148:Spironolactone / Q000633:toxicity*; D013737:Testis / Q000187:drug effects* / Q000502:physiology; D013739:Testosterone / Q000097:blood
D013148:Spironolactone; D013739:Testosterone; D004958:Estradiol; D002192:Canrenone; D002191:Canrenoic Acid; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone